glp 1 inflammatory bowel disease Frontiers SAFETY AND CLINICAL EFFECTIVENESS OF
Description
Evidence from experiments employing somatostatin receptor 2 (SSRT2) antagonists and SSRT2 knockout mice strongly suggests that GLP-1s inhibitory actions on -cells are indirect and partially mediated through somatostatin-dependent mechanisms (132)
This article contains affiliate links
Finally, the GLP-1 effects on insulin secretion are dependent on the metabolic state of the individual
GLP-1, or glucagon-like peptide-1, is a hormone produced in the gut in response to eating
7 The good news is that for many people, these side effects are mild to moderate and tend to lessen or resolve over time (often within a few weeks to months) as the body adjusts
